A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Macular Edema

In brief

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of diabetic macular edema.

Key facts

Study ID

NCT00168337

Run by

Allergan

People needed

554

Starts

2005-05-01

Expected to finish

2012-05-01

Last updated by the study team

2014-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Artesia, California, United States
• Study site — São Paulo, Brazil
• Study site — Mississauga, Ontario, Canada
• Study site — Bogotá, Colombia
• Study site — Dijon, France
• Study site — Budapest, Hungary
• Study site — New Delhi, India
• Study site — Milan, Italy
• Study site — Auckland, New Zealand
• Study site — Warsaw, Poland
• Study site — Singapore, Singapore
• Study site — Seoul, South Korea
• Study site — Taipei, Taiwan
• Study site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.